SEARCH RESULTS FOR: "Tag: FOLD"
loading image
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(1)
ARTICLES/BLOGS
2021(1)
2020(1)
2019(2)
2018(1)
2017(8)
2016(2)
2015(7)
2014(1)
CATEGORIES
Analyst Downgrades(1)
Analyst Update(1)
Analyst Upgrades(1)
Best and Worst Stocks(1)
Buzz Stocks(4)
By the Numbers(1)
Earnings Preview(1)
Expectational Analysis(1)
General(3)
Indexes and ETFs(1)
Intraday Option Activity(2)
Investor Sentiment(1)
Midday Market Check(2)
Opening View(1)
Quantitative Analysis(4)
Stock Market News(3)
Stocks On the Move(2)
Technical Analysis(1)

10/18/2021 11:56 AM
It has been a rocky year for Amicus Therapeutics, Inc. (NASDAQ:FOLD), after the stock suffered a dramatic bear gap back in February that it hasn't even come close to recovering from. In recent months...
11/24/2020 1:01 PM
The shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) are up 1.3% at $22.69 at last check, after hitting a Nov. 18, all-time-high of $23.19. And while the security is now cooling off from that record,...
11/7/2019 11:41 AM
Biopharmaceutical name Amicus Therapeutics, Inc. (NASDAQ:FOLD) is expected to disclose its third-quarter earnings report before the open next Monday, Nov. 11. The stock is inching higher ahead of the...
4/15/2019 3:36 PM
Pharmaceutical name Amicus Therapeutics, Inc. (NASDAQ:FOLD) has put on quite the performance this year -- outperforming the broader S&P 500 Index (SPX) by 16% during the past two months. The security ...
11/6/2018 10:14 AM
Amicus Therapeutics, Inc. (NASDAQ:FOLD) and Mylan N.V. (NASDAQ:MYL) both reported third-quarter earnings yesterday evening, and analysts are reacting to the numbers. Below is a brief breakdown of t...
 
Special Offers from Schaeffer's Trading Partners